Loading clinical trials...
Loading clinical trials...
Multi Institutional Phase II Trial of Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Conditions
Interventions
Regorafenib
Locations
3
United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
VCU Massey Cancer Center
Richmond, Virginia, United States
Start Date
June 5, 2014
Primary Completion Date
December 10, 2018
Completion Date
September 20, 2021
Last Updated
October 12, 2021
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions